Answers are grounded in this paper and cite their sources.
Reinvestigation of mycothiazole ( 1 ) revealed picomolar potency (IC 50 = 0.00016, 0.00027, 0.00035 μM) against pancreatic, (PANC-1), liver (HepG2), and colon (HCT-116) tumor cell lines. Reevaluation of 1 provided [α] D data indicating Vanuatu specimens of C. mycofijiensis contain the 8 S enantiomer of 1 and not the 8 R configuration previously reported. Semisynthesis provided 8- O -acetylmycothiazole ( 2 ), 8-oxomycothiazole ( 8 ), mycothiazole nitrosobenzene derivatives (MND1, MND2: 9a, 9b ), and MND3 ( 10 ) with IC 50 = 0.00129, >1.0, >1.0, >1.0, >1.0 μM, respectively, against PANC-1 cell lines. These results highlight the significance of the penta-2,4-dien-1-ol residue as a key structural feature of 1 required for its cytotoxicty against tumor cell lines.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: